MF
Martin Fan Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
21
Avg Return
Past Year
Past Year
42%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
89.5%
Neutral
5.3%
Negative
5.3%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Reiterated
| $45 |
35%
downside
| 3 | +69% |
0
%
| 13 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $75 |
27%
upside
| 5 | +28% |
0
%
| 12 Mar ‘26 1 month ago |
|
|
|
Outperform
Reiterated
| $38 |
463%
upside
| 2 | -18% |
0
%
| 10 Mar ‘26 1 month ago |
|
|
|
Outperform
Initiated
| $15 |
179%
upside
| 1 | +5% |
0
%
| 9 Feb ‘26 2 months ago |
|
|
|
Outperform
Reiterated
| $45 |
147%
upside
| 3 | +72% |
0
%
| 22 Dec ‘25 4 months ago |
|
|
|
Neutral
Assumed
| $9 |
35%
downside
| 1 | – |
–
| 25 Nov ‘25 5 months ago |
|
|
|
Underperform
Assumed
| $2 |
65%
downside
| 1 | +9.3% |
0
%
| 25 Nov ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $6 |
82%
upside
| 2 | +3.5% |
0
%
| 7 Nov ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $23 |
123%
upside
| 2 | +48% |
0
%
| 17 Oct ‘25 6 months ago |
|
|
|
Outperform
Initiated
| $8 |
86%
upside
| 1 | +198% |
0
%
| 28 May ‘25 11 months ago |
|